Australia - English - Department of Health (Therapeutic Goods Administration)

molnlycke health care pty ltd - 59523 - non-sterile wound irrigation solution, antimicrobial - granudacyn? wound gel is a ready-to-use, clear gel for cleaning and moistening acute and chronic wounds as well as for keeping wounds moist. granudacyn? wound gel may be used for the thorough wound cleaning of: ? acute or chronic wounds as well as surface wounds ? cuts, abrasions and 1st and 2nd degree burns ? critically colonised or infected wounds

Australia - English - Department of Health (Therapeutic Goods Administration)

molnlycke health care pty ltd - 59523 - non-sterile wound irrigation solution, antimicrobial - this devices is a ready-to-use, wound irrigation solution for the cleaning and irrigation of acute, chronic and contaminated wounds. granudacyn? can be used for the thorough cleaning of: ? all chronic wounds of any depth, such as: diabetic foot ulcer, all forms of leg ulcer, pressure sores ? all acute wounds such as cuts, bites, lacerations, burst wounds and abrasions ? surgical wounds (intraoperative and postoperative) ? wounds with exposed cartilage, tendons, ligaments or bone ? 1st and 2nd degree burns ? radiation ulcers ? fistulas and abscesses ? body cavities such as the mouth, nose and ears ? critically colonized or infected wounds ? soft tissue injuries granudacyn? wound irrigation solution can be used for instillation in negative pressure wound therapy (npwt).

Singapore - English - HSA (Health Sciences Authority)

siemens healthcare pte. ltd. - radiology / imaging - the magnetom system is indicated for use as a magnetic resonance diagnostic device (mrdd) that produces transverse, sagittal, coronal and oblique cross sectional images, spectroscopic images and/or spectra, and that displays the internal structure and/or function of the head, body, or extremities. other physical parameters derived from the images and/or spectra may also be produced. depending on the region of interest, contrast agents may be used. these images and/or spectra when interpreted by a trained physician yield information that may assist in diagnosis. the magnetom system may also be used for imaging during interventional procedures when performed with mr compatible devices such as in room display and mr-safe biopsy needles.

Israel - English - Ministry of Health

teva israel ltd - tamoxifen as citrate - tablets - tamoxifen as citrate 20 mg - tamoxifen - tamoxifen - for the palliative treatment of breast cancer generally in post menopausal women, either alone or in combination with other modalities.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - amoxicillin trihydrate, quantity: 1012.617 mg (equivalent: amoxicillin, qty 875 mg); potassium clavulanate, quantity: 149.774 mg (equivalent: clavulanic acid, qty 125 mg) - tablet, film coated - excipient ingredients: dichloromethane; isopropyl alcohol; magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; sodium starch glycollate type a; titanium dioxide; hypromellose; purified talc; diethyl phthalate; ethylcellulose - clavamox tablets are indicated for short term treatment of bacterial infections at the following sites when caused by sensitive organisms (refer to microbiology):,urinary tract infections (uncomplicated and complicated), lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis, upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis.skin and skin structure infection.,appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to clavamox tablets. however, when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. once these results are known, therapy should be adjusted if appropriate.,the treatment of mixed infections caused by amoxycillin susceptible organisms and beta-lactamase producing organisms susceptible to clavamox tablets should not require the addition of another antibiotic due to the amoxycillin content of these products.

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amoxicillin trihydrate, quantity: 1004.5 mg (equivalent: amoxicillin, qty 875 mg); potassium clavulanate, quantity: 148.87 mg (equivalent: clavulanic acid, qty 125 mg) - tablet, film coated - excipient ingredients: ethylcellulose; purified talc; triethyl citrate; polysorbate 80; crospovidone; croscarmellose sodium; magnesium stearate; hyprolose; microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide - amoxycillin and clavulanic acid tablets are indicated for short term treatment of bacterial infections at the following sites when caused by sensitive organisms (refer to microbiology): urinary tract infections (uncomplicated and complicated); lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis; upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis; skin and skin structure infections. appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to amoxycillin and clavulanic acid tablets. however, when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. once these results are known, therapy should be adjusted if appropriate. the treatment of mixed infection

Australia - English - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - paracetamol, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections; mannitol; sodium hydroxide; dibasic sodium phosphate dihydrate; povidone - paracetamol bnm 1000mg/100ml, solution for infusion is indicated for the relief of mild to moderate pain and the reduction of fever where an intravenous route of administration is considered clinically necessary.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - paracetamol, quantity: 500 mg; codeine phosphate hemihydrate, quantity: 30 mg - tablet, uncoated - excipient ingredients: potassium sorbate; maize starch; povidone; purified talc; stearic acid; magnesium stearate; microcrystalline cellulose; croscarmellose sodium; pregelatinised maize starch - paracetamol/codeine gh 500/30 is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Israel - English - Ministry of Health

neopharm (israel) 1996 ltd - paracetamol - solution for infusion - paracetamol 10 mg/ml - paracetamol - paracetamol – fresenius is indicated for:- the short-term treatment of moderate pain, especially following surgery- the short-term treatment of fever.when administration by intravenous route is clinically justified by an urgent need to treat pain or hyperthermia and/or when other routes of administration are not possible.

Israel - English - Ministry of Health

neopharm (israel) 1996 ltd - paracetamol - solution for infusion - paracetamol 10 mg/ml - paracetamol - paracetamol – fresenius is indicated for:- the short-term treatment of moderate pain, especially following surgery- the short-term treatment of fever.when administration by intravenous route is clinically justified by an urgent need to treat pain or hyperthermia and/or when other routes of administration are not possible.